Helena Teede
Tracked across 2 events · 95 articles · First seen May 12, 2026 · Last active May 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Tech
Polycystic ovary syndrome (PCOS), a hormonal condition affecting over 170 million women globally, has been officially renamed Polyendocrine metabolic ovarian syndrome (PMOS). This change, published in The Lancet and led by Monash University and the…
Impact: Helena Teede, Director of the Monash Centre for Health Research & Implementation, led the global effort to rename Polycystic ovary syndrome to Polyendocrine metabolic ovarian syndrome, advocating for better understanding and care.
May 12, 2026 · 67 articles
Tech
Polycystic ovary syndrome (PCOS) has been officially renamed polyendocrine metabolic ovarian syndrome (PMOS) after a 14-year international initiative led by Helena Teede and involving over 50 patient advocacy and medical organizations, including the Pediatric Endocrine…
Impact: Helena Teede led the 14-year international initiative to rename PCOS to PMOS, aiming to improve diagnosis and care for women worldwide. She is a key figure in this landmark medical change.
May 13, 2026 · 28 articles
90
Helena Teede chaired steering group Polyendocrine metabolic ovarian syndromePCOS Renamed Polyendocrine...
70
Helena Teede led researchPCOS Renamed to PMOS Globally
60
Helena Teede described conditionPCOS Renamed to PMOS Globally
NEWSDESK
Track Helena Teede live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard